Zilis Experiences Over 500% Recruitment Growth with New Enrollment Program

By: Issuewire
Zilis

For Immediate Release

Argyle, Nov 20, 2020 (Issuewire.com) - Zilis LLC, a CBD industry leader, has announced a record surge in recruitment activity, following the recent announcement of their new Stimulus enrollment package.

This enrollment package includes two of their flagship UltraCell products, and waives the $99 enrollment fee, allowing customers to start their Zilis business for free. Valued at $180, the Stimulus package is available for $49.

Steven Thompson, CEO and Founder of Zilis, explained the impact of this new program, "We knew that the Stimulus package announcement would have a significant impact on our business, but with more than 500% growth in new recruitment in just four days, this program has exceeded our expectations."

He added, "Based on the rapid success of the Stimulus package, and the unprecedented number of people who are searching for new income opportunities, we expect to enroll thousands of new Ambassadors in the coming months."

Zilis announced the Stimulus enrollment package at their U.S. and European virtual Freedom Summits on November 14, seen by thousands around the world.

About Zilis LLC
As a hybrid social marketing company focused on endocannabinoid system health, Zilis is the creator of hemp-derived products including UltraCell, UltraCell Topical, UltraCell Powder, UltraCell Pet, UltraCBG, UltraBliss, UltraR&R, and UltraReVV, and hemp-free products including a line of boosters to support specific areas of wellness, and their UltraSupport line of health supplements. Zilis trusts its distributed workforce of Independent Ambassadors to sell its products to customers either independently or through their Ambassador retail business. Based in Argyle, Texas, a suburb of Dallas-Ft. Worth, Zilis is privately held.

Business from anywhereNew Stimulus Program

Media Contact

Zilis LLC/Amanda Green


marketing@zilis.com

214-705-3702

415 US Hwy 377, STE 2020

https://zilis.com

Source :Zilis LLC

This article was originally published by IssueWire. Read the original article here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.